Padyukov, L <br/><br/>
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jun 2003 
 - 526-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.62.6.526  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Cytokines--genetics<br/>Etanercept<br/>Female<br/>Genetic Markers<br/>Genotype<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Male<br/>Middle Aged<br/>Patient Selection<br/>Polymorphism, Genetic<br/>Prognosis<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Recombinant Fusion Proteins--therapeutic use<br/>Treatment Outcome